摘要:
The invention relates to novel fused heterocyclic compounds with ring junction nitrogen atom of formula (I), wherein Q stands for 2-indolizinyl, 2-imidazo[1,2-a]pyridinyl, 2-imidazo[1,2-a]pyrimidinyl, 6-(2,3-dihydroimidazo[2,1-b]thiazol)-yl or 6-imidazo[2,1-b]thiazolyl group; and n is an integer from 2 to 4, as well as their therapeutically useful salts thereof. The invention further relates to pharmaceutical compositions containing these compounds as well as a process for the preparation of the above compounds and compositions. The novel compounds of formula (I) exhibit mainly antipsychotic effects so the invention relates also to a method of treatment of schizophrenia, organic mental disorders, affective disorders, anxiety and personality disorders.
摘要:
The invention relates to new piperidinoalkyl aryl ethers of formula (I), wherein R means hydrogen or a C1-4alkyl group; X stands for hydrogen; halogen; C1-4alkyl; C1-4alkoxy; phenyl; 2,3-(CH=CH)2-; 3,4-(CH=CH)2-; or 3,4-(CH2)3-CO-group; n is an integer from 2 to 4; v is an integer from 1 to 5; m is an integer from 1 to 3; Y means hydrogen or halogen, as well as their pharmaceutically acceptable acid addition salts. The invention relates also to a process for the preparation of compounds of formula (I), as well as to pharmaceutical compositions containing the compounds of formula (I) as active ingredients. The compounds of the invention are new and possess a significant biological activity, such as antioxidant (lipid peroxidation-inhibiting), antihypoxic and antiamnesic effects.